Add time:09/28/2019 Source:sciencedirect.com
SummaryA series of 103 patients undergoing radiation therapy for carcinoma of the larynx, oesophagus, breast, bronchus and the reticuloses, on whom a clinical trial of aludrox and Oxethazaine (cas 126-27-2) was performed in an attempt to relieve their symptoms of radiation-induced sore throat and oesophagitis, has been reviewed.It would appear from this clinical trial, in which 75 per cent of the patients gained relief from their symptoms, that ‘Mucaine’ is a good medication, provided it is used at the onset of the symptoms, as late administration renders little relief.
We also recommend Trading Suppliers and Manufacturers of Oxethazaine (cas 126-27-2). Pls Click Website Link as below: cas 126-27-2 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View